Caregiving is no longer something columnist Samuel Ike does. It has become part of the way he exists, settling over him like ...

A U.S. developer is seeking FDA approval of a second-generation infusion therapy for those with relapsed or hard-to-treat ...

The Pancreatic Cancer Awareness Month 2026 campaign is highlighting the importance of early detection with webinars and ...

Jakafi is no better than older therapies at inducing a complete response in PV, but may be better at easing certain symptoms, ...

For columnist Samuel Ike, learning to leave the room and take a short break has been one of the hardest parts of caregiving.

The International Myeloma Foundation formed a network aiming to expand access to clinical trials for people with myeloma.

Changes in blood LDH levels may offer clues about glioblastoma progression alongside brain scans, according to a small ...

The FDA has granted orphan drug designation to onvansertib as a potential treatment for CMML, a form of blood cancer.

Columnist Gina Diamante often warns people about how social media is a place that can lead to conclusions that are scary and ...

Between columnist Gina Diamante's myeloma and her husband Tony's disability, they're constantly learning to navigate being care partners.

A Phase 2 trial of a four-drug regimen including Sarclisa Escena (isatuximab-irfc) showed promising treatment responses in people ages 65 and older with newly diagnosed myeloma who were not eligible ...